Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions
Covered official positions, as disclosed on federal filings
The past 12 months
Clients
19
past 12 months
Filings
33
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESSENATEExecutive Office of the President (EOP)Health & Human Services, Dept of (HHS)
Specific issues
Medicaid State-Directed Payments and Intergovernmental Transfers.
Medicare/Medicaid · 2026 Q2
Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs.
Health Issues · 2026 Q2
Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs. Drug pricing reform. Food and Drug Administration legislative and regulatory issues.
Pharmacy · 2026 Q2
Issues related to access to rare disease therapies, diagnosis and testing. Issues related to FDA modernization and rare disease drug development. Issues related to the Accelerated Approval Program. Issues related to Public Law No. 117-169 - The Inflation Reduction Act of 2022. Issues related to alternative funding programs. Issues related to the Rare Pediatric Disease Priority Review Voucher program, including H.R.1262/S.932 - Give Kids a Chance Act of 2025.
Health Issues · 2026 Q2
Issues related to USTR/trade.
Trade (domestic/foreign) · 2026 Q2
Pharmaceutical Supply Chain. H.R.2213: Medical Supply Chain Resiliency Act. Issues related to the 340(b) program. H.R.1492/S.832: EPIC Act of 2025.